| Patents for C07K - Peptides (3,738) |
|---|
| 10/28/2004 | CA2522525A1 Chimeric polypeptides comprising a type ii restriction endonuclease |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | CA2521174A1 Enhanced hiv-1 vaccines and methods for their use |
| 10/28/2004 | CA2520323A1 Tie-2 modulators and methods of use |
| 10/27/2004 | EP1469869A2 Peptide useful in immunomodulation |
| 10/27/2004 | CN1541225A Humanized antibodies that recognize beta amyloid peptide |
| 10/21/2004 | WO2004089972A2 Mass spectrometry data analysis techniques |
| 10/21/2004 | WO2004009776A3 TREATMENT OF TNFα RELATED DISORDERS |
| 10/21/2004 | US20040209276 Heat resistant polymerases for use in propagation and replication of nucleic acids |
| 10/21/2004 | US20040208850 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 10/21/2004 | CA2521034A1 Mass spectrometry data analysis techniques |
| 10/14/2004 | WO2004087737A2 Omega-3 fatty acid assays for disease risk assessment |
| 10/14/2004 | WO2004087736A2 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 10/14/2004 | WO2004087734A2 Stq-peptides |
| 10/14/2004 | WO2004087733A2 Prevention and treatment of alzheimer amyloid deposition |
| 10/14/2004 | WO2004087732A2 Process for the preparation of (1s, 4s)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-naphthylamine |
| 10/14/2004 | WO2004043988A3 Ptprk immunogenic peptide |
| 10/14/2004 | US20040204412 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer |
| 10/14/2004 | US20040204346 Intermediate for preparing glycopeptide derivatives |
| 10/14/2004 | CA2520372A1 Stq-peptides |
| 10/13/2004 | EP1465656A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 10/13/2004 | EP1257584B1 Humanized antibodies that sequester amyloid beta peptide |
| 10/13/2004 | EP0637933B1 Method for treating organs and tissues |
| 10/12/2004 | US6803361 Administering nucleotide sequence |
| 10/07/2004 | WO2004037852A3 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility |
| 10/07/2004 | US20040195500 Mass spectrometry data analysis techniques |
| 10/06/2004 | EP1464705A1 Optimizing cells for endogenous gene activation |
| 10/06/2004 | EP0869810B1 Cyclosporin-containing soft capsule preparations |
| 10/06/2004 | CN1535313A Protein C or activated protein C-like molecules |
| 09/30/2004 | WO2004083236A2 Cancer treatment using proanp peptides |
| 09/30/2004 | WO2004083235A2 Tie-2 modulators and methods of use |
| 09/30/2004 | WO2004083234A2 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 09/30/2004 | WO2004083232A2 Receptor proteins |
| 09/30/2004 | WO2004074313A8 Methods for prediction of amyloid fibril formation and identification of peptides useful as therapeutic and diagnostic agents |
| 09/30/2004 | WO2004029070A3 Methods for blocking adipocyte differentiation and triglyceride accumulation with dual-specificity tyrosine- (y) - phosphorylation regulated kinase 4 (dyrk4) inhibitors |
| 09/30/2004 | US20040192609 Peptides binding gp120 of HIV-1 |
| 09/30/2004 | US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/30/2004 | CA2518550A1 Cancer treatment using proanp peptides |
| 09/29/2004 | EP1461079A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 09/29/2004 | EP1084147B1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 09/29/2004 | EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials |
| 09/28/2004 | CA2191088C Copolymer-1 improvements in compositions of copolymers |
| 09/23/2004 | WO2004081033A2 Synthesis of proteins by cell-free protein expression |
| 09/23/2004 | WO2004081032A2 Novel litaf binding site peptides and methods of using the same |
| 09/23/2004 | WO2004081031A2 Thiol-mediated drug attachment to targeting peptides |
| 09/23/2004 | WO2004081030A2 Peptides selectively lethal to malignant and transformed mammalian cells |
| 09/23/2004 | WO2004081029A2 Novel non-invasive marker for liver disease |
| 09/23/2004 | WO2004066914A3 Variant integrin polypeptides and uses thereof |
| 09/23/2004 | WO2004037847A3 Hiv envelope-cd4 complexes and hybrids |
| 09/23/2004 | CA2518406A1 Thiol-mediated drug attachment to targeting peptides |
| 09/22/2004 | EP0938500B1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/22/2004 | EP0636179B1 Oil-body proteins as carriers of high-value peptides in plants |
| 09/16/2004 | WO2004078778A2 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF |
| 09/16/2004 | WO2004078776A2 Ny-eso-1 peptides which bind to class ii molecules and uses thereof |
| 09/16/2004 | WO2004078775A2 Intracellular signaling-induced ret-independent gdnf receptor-effected morphological changes |
| 09/16/2004 | WO2004065406A3 Rantes-derived peptides with anti-hiv activity |
| 09/16/2004 | WO2004058798A3 Antimicrobial peptides |
| 09/16/2004 | WO2004052916A3 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids |
| 09/16/2004 | WO2004050679A3 Mutant glycoproteins |
| 09/16/2004 | US20040181035 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 09/16/2004 | CA2517939A1 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 09/15/2004 | EP1456230A2 Flavivirus ns1 subunit vaccine |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | CN1166681C Preparation of purified (poly) peptides |
| 09/10/2004 | WO2004076474A2 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 09/10/2004 | WO2004076473A2 Androgen receptor interacting peptides |
| 09/10/2004 | WO2004058799A3 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 09/10/2004 | WO2004031210A3 Optimized multi-epitope constructs and uses thereof |
| 09/10/2004 | WO2003087123A3 Methods and kits for testing mutagenicity |
| 09/10/2004 | CA2516552A1 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 09/09/2004 | US20040176375 Benzene acetamide compounds useful as serine protease inhibitors |
| 09/08/2004 | EP1453859A2 Chemically-modified human growth hormone conjugates |
| 09/02/2004 | WO2004074315A2 Analogues of glp-1 |
| 09/02/2004 | WO2004074313A2 Methods for prediction of amyloid fibril formation and identification of peptides useful as therapeutic and diagnostic agents |
| 09/02/2004 | WO2004074312A2 Tryptophyllin peptides and uses thereof |
| 09/02/2004 | WO2004074310A2 Mycobacterial diagnostics |
| 09/02/2004 | WO2004073736A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 09/02/2004 | WO2004046365A3 Interferon-alpha polypeptides and conjugates |
| 09/02/2004 | WO2004041845A3 Templated native silk smectic gels |
| 09/02/2004 | CA2513307A1 Analogues of glp-1 |
| 09/02/2004 | CA2498650A1 Mycobacterial diagnostics |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 08/26/2004 | WO2004072105A2 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
| 08/26/2004 | WO2004072104A2 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
| 08/26/2004 | WO2004072103A2 Macromolecule identification made by mass spectrometry and database searching |
| 08/26/2004 | WO2004072102A2 Benzene acetamide compounds useful as serine protease inhibitors |
| 08/26/2004 | WO2004072101A2 Phenylglycine derivatives useful as serine protease inhibitors |
| 08/26/2004 | WO2004072100A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | WO2004072099A2 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41 |
| 08/26/2004 | WO2004072098A2 Immunocompromised rodents as dual color tumor models |
| 08/26/2004 | WO2004072097A2 A microchip-based system for hiv diagnostics |
| 08/26/2004 | WO2004072096A2 Peptides binding gp120 of hiv-1 |
| 08/26/2004 | WO2004072095A2 Cyclized peptides as exotoxin antagonists |
| 08/26/2004 | WO2004072094A2 Hmgb1 modulator binding domain |
| 08/26/2004 | WO2004071387A2 Hsp60 from arthrobacter |
| 08/26/2004 | US20040167332 Boronic ester and acid compounds, synthesis and uses |
| 08/26/2004 | CA2515651A1 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
| 08/26/2004 | CA2515208A1 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | CA2515203A1 Immunocompromised rodents as dual color tumor models |
| 08/26/2004 | CA2513061A1 Hsp60 from arthrobacter |